Cardiology is at an inflection point.
Procedures once performed almost exclusively in hospitals — diagnostic catheterization, a growing list of interventional cases, and EP studies, ablations, and more PCI — are steadily shifting to ambulatory surgery centers. CMS keeps expanding what ASCs can perform, payers favor lower-cost sites of service, and patients increasingly seek care that balances safety with convenience
That shift doesn’t land the same way for everyone. For hospitals, it puts cardiovascular revenue and physician alignment at risk. For cardiologists, it opens real decisions about ownership, partnership, and independence. For ASC owners weighing a new cardiovascular line, it’s one of the most significant opportunities in years — and a moment where the right non-equity ASC management partner can help them add the service without giving up ownership or control.
Developed by the outpatient advisory experts at Avanza + MedHQ — a non-equity ASC management company built to help surgery centers and physician practices thrive on their own terms — this white paper maps where cardiology is headed and gives each stakeholder a clear set of next steps, so you can respond deliberately instead of reacting after the market has already moved.
